|
|
ANORO ELLIPTA 55/22 INHR (GSK/COL) UMECLIDINI
|
|
|
|
|
|
4892
|
|
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
Moderate to severe chronic obstructive pulmonary disease (COPD).
|
|
|
As for Vilanterol/Fluticasone; The inhaler should be discarded 6 weeks after opening.
|
|
|
One inhalation once daily at the same time each day .
|
|
|
|
|
|
|
|
|
|
|
|
|